Metipranolol
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-4-{[-2-hydroxy-3-(isopropylamino)propyl]oxy}-2,3,6-trimethylphenyl acetate | |
| Clinical data | |
| Trade names | Optipranolol |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a601078 |
| Identifiers | |
| CAS Number | 22664-55-7 |
| ATC code | S01ED04 (WHO) C07BA68 |
| PubChem | CID 31477 |
| IUPHAR/BPS | 7239 |
| DrugBank |
DB01214 |
| ChemSpider |
29193 |
| UNII |
X39AL81KEB |
| KEGG |
D02374 |
| ChEMBL |
CHEMBL1291 |
| Chemical data | |
| Formula | C17H27NO4 |
| Molar mass | 309.401 g/mol |
| Chirality | Racemic mixture |
| |
| |
| (verify) | |
Metipranolol (OptiPranolol, Betanol, Disorat, Trimepranol) is a non-selective beta blocker used in eye drops to treat glaucoma. It is rapidly metabolized into desacetylmetipranolol.[1]
References
- ↑ Maffei Facino, R.; Bertuletti, R.; Carini, M.; Tofanetti, O. (1980). "In vitro metabolism of methypranolol by rat liver". Analytical Chemistry Symposia Series 4 (6): 217–223.
| ||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
